| 000 | 01627 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517035331.0 | ||
| 264 | 0 | _c20160401 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/03007995.2015.1062358 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Nanxin | |
| 245 | 0 | 0 |
_aEverolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cAug 2015 |
||
| 300 |
_a1573-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
| 650 | 0 | 4 |
_aEverolimus _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xsecondary |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aHao, Yanni | |
| 700 | 1 | _aXie, Jipan | |
| 700 | 1 | _aLin, Peggy L | |
| 700 | 1 | _aZhou, Zhou | |
| 700 | 1 | _aZhong, Yichen | |
| 700 | 1 | _aSignorovitch, James E | |
| 700 | 1 | _aWu, Eric Q | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 31 _gno. 8 _gp. 1573-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007995.2015.1062358 _zAvailable from publisher's website |
| 999 |
_c24981524 _d24981524 |
||